Evolution News and Research RSS Feed - Evolution News and Research

Endo International’s revenues increase $800 million to 37% in fourth quarter 2014

Endo International’s revenues increase $800 million to 37% in fourth quarter 2014

Endo International plc today reported fourth quarter 2014 revenues of $800 million, an increase of 37 percent compared to fourth quarter 2013 revenues of $585 million, including new product revenue from 2014 strategic M&A transactions. [More]

Qualcomm launches Snapdragon Sense ID 3D Fingerprint Technology

Qualcomm Technologies, Inc., a subsidiary of Qualcomm Incorporated, is extending its mobile security leadership with the launch of Qualcomm Snapdragon Sense ID 3D Fingerprint Technology, the mobile industry's first 3D fingerprint authentication technology based on ultrasonic technology. [More]
New book provides in-depth, advanced understanding of Ebola and rabies viruses

New book provides in-depth, advanced understanding of Ebola and rabies viruses

Significant human and animal pathogens remain major scourges to human health. Recent devastating Ebola virus disease outbreak in West Africa underscores the importance of understanding the biology of replication and response of host cells to infection by these pathogens. [More]
Drosophila Research Conference to highlight recent advances in genetics research

Drosophila Research Conference to highlight recent advances in genetics research

Over 1,500 scientists from 30 countries and 46 states will attend next week's 56th Annual Drosophila Research Conference organized by the Genetics Society of America, March 4–8 in Chicago, IL. [More]
Single-step fermentative method may facilitate industrial-scale statin drug production

Single-step fermentative method may facilitate industrial-scale statin drug production

University of Manchester researchers, together with industrial partner DSM, have developed a single-step fermentative method for the production of leading cholesterol-lowering drug, pravastatin, which will facilitate industrial-scale statin drug production. [More]
Researchers reveal that mosquitoes’ sexual biology may key to malaria transmission

Researchers reveal that mosquitoes’ sexual biology may key to malaria transmission

Sexual biology may be the key to uncovering why Anopheles mosquitoes are unique in their ability to transmit malaria to humans, according to researchers at Harvard T. H. Chan School of Public Health and University of Perugia, Italy. [More]
MIT researchers devise new way to make complex emulsions

MIT researchers devise new way to make complex emulsions

MIT researchers have devised a new way to make complex liquid mixtures, known as emulsions, that could have many applications in drug delivery, sensing, cleaning up pollutants, and performing chemical reactions. [More]
Esaote introduces eXP technology-powered EVOLUTION’15 at ECR 2015

Esaote introduces eXP technology-powered EVOLUTION’15 at ECR 2015

At ECR 2015 Esaote, a world leading manufacturer of medical diagnostic systems, introduces Evolution’15 (EVO’15) as the latest upgrade in its dedicated MRI Evolution program. EVO’15 combines software updates and new hardware features to provide superb image quality and increases productivity by almost 50%. [More]
N30 Pharmaceuticals becomes Nivalis Therapeutics

N30 Pharmaceuticals becomes Nivalis Therapeutics

N30 Pharmaceuticals, Inc., a clinical-stage pharmaceutical company focused on the development of product candidates for cystic fibrosis (CF), announced today that the Company has changed its name to Nivalis Therapeutics, Inc. The Company's lead product candidate, N91115, is a novel inhibitor of S-nitrosoglutathione reductase (GSNOR). [More]
Accuray, Lancaster announces commercial availability of InCise MLC for CyberKnife M6 System

Accuray, Lancaster announces commercial availability of InCise MLC for CyberKnife M6 System

Accuray Incorporated and Lancaster General Health announced today that the first commercially available InCise Multileaf Collimator (MLC) for the CyberKnife M6 System has been received by Lancaster. [More]
Study suggests that antibiotics can induce potentially dangerous biofilm formation

Study suggests that antibiotics can induce potentially dangerous biofilm formation

Most people have taken an antibiotic to treat a bacterial infection. Now researchers from the University of North Carolina at Chapel Hill and the University of San Diego, La Jolla, reveal that the way we often think about antibiotics - as straightforward killing machines - needs to be revised. [More]
Nuo Therapeutics initiates phase 4 study of Aurix™ under CMS coverage with evidence development program

Nuo Therapeutics initiates phase 4 study of Aurix™ under CMS coverage with evidence development program

Nuo Therapeutics, Inc. (OTCQX:NUOT), a pioneer in biodynamic therapies, today announced the initiation of a new clinical study (Au Study) that is comprised of three randomized controlled protocols that examine the efficacy of Aurix™, a biodynamic hematogel, for use in diabetic foot ulcers, venous leg ulcers and pressure ulcers (bed sores). [More]
MD Anderson awarded more than $22 million in research grants from CPRIT

MD Anderson awarded more than $22 million in research grants from CPRIT

The University of Texas MD Anderson Cancer Center has received more than $22 million in research grants this week from the Cancer Prevention and Research Institute of Texas. Approximately half of the funds awarded for Individual Investigator Research Awards went to MD Anderson faculty as well as 40 percent of total IIRA awards that include those for children's and adolescent cancer and early detection and prevention. [More]
Saluda Medical receives $10 million in Series B financing

Saluda Medical receives $10 million in Series B financing

Saluda Medical has today announced that it has received $10 million in Series B financing bringing a breakthrough treatment for chronic pain one step closer to reality. [More]
Evolution of two protein kinases may hold key to unlocking highly specific cancer drugs

Evolution of two protein kinases may hold key to unlocking highly specific cancer drugs

This is the story of Abl and Src -- two nearly identical protein kinases whose evolution may hold the key to unlocking new, highly specific cancer drugs. [More]
Einstein researchers find possible clue to why older mothers have babies born with Down syndrome

Einstein researchers find possible clue to why older mothers have babies born with Down syndrome

Researchers at Albert Einstein College of Medicine of Yeshiva University have found a possible clue to why older mothers face a higher risk for having babies born with conditions such as Down syndrome that are characterized by abnormal chromosome numbers. [More]
Actavis provides overview of standalone global pharmaceutical development pipeline

Actavis provides overview of standalone global pharmaceutical development pipeline

Actavis plc, during its Investor Meeting in New York, today provided a detailed look into its standalone global pharmaceutical development pipeline that supports the Company's long-term organic growth. The Company provided details regarding key development programs, including clinical data, development milestones and an overview of potential market opportunities, as well as an updated look at Actavis' world-class generics pipeline, which continues to hold an industry-leading position in First-to-File opportunities in the U.S. [More]
Researchers show importance of DNA damage in fine tuning of innate immune system

Researchers show importance of DNA damage in fine tuning of innate immune system

For the first time scientists from Umeå University show the importance of DNA damage in fine tuning of our innate immune system and hence the ability to mount the optimal inflammatory response to infections and other biological dangers. [More]
Football injuries more frequent in competition matches than during training sessions

Football injuries more frequent in competition matches than during training sessions

The risk of injury during competition matches is twelve times higher than during training sessions in players of the Professional Football League. The most common ones are muscular injuries and those resulting from overexertion, which imply recovery periods of around one week. [More]
Research: Complex nerve circuits first evolved in common ancestor of humans and cnidarians

Research: Complex nerve circuits first evolved in common ancestor of humans and cnidarians

New research shows that a burst of evolutionary innovation in the genes responsible for electrical communication among nerve cells in our brains occurred over 600 million years ago in a common ancestor of humans and the sea anemone. [More]